Makes titanium implants for sacroiliac joint dysfunction and pelvic trauma.
Jun 2026Revenue $214M/yrExpenses $231M/yr
Expected break-even Nov 2027Cash runway ≈ 7.6 years from Jun 2026
Figures by year
When will SI-BONE be profitable?
Its revenue and expense trends are projected to cross in Nov 2027. In the 12 months to Jun 2026, revenue was $214M and expenses $231M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $201M | $223M | −$22.3M |
| Dec 2024 | $167M | $202M | −$35.2M |
| Dec 2023 | $139M | $186M | −$46.9M |
| Dec 2022 | $106M | $166M | −$59.6M |
| Dec 2021 | $90.2M | $142M | −$51.7M |
| Dec 2020 | $73.4M | $112M | −$38.6M |
| Dec 2019 | $67.3M | $103M | −$36.0M |
| Dec 2018 | $55.4M | $67.3M | −$12.0M |
| Dec 2017 | $48.0M | $65.3M | −$17.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.